Risk factors for coronary atherosclerotic heart disease in postmenopausal women: a meta-analysis

Xin Miao1,2, Lixing Wu3, Kuiyue Wang4

  • 1Department of Nursing, School of Medical and Health Engineering, Changzhou University, Changzhou, Jiangsu, China.

PubMed

Insights

A history of six or more pregnancies significantly increases the risk of coronary heart disease (CHD) in postmenopausal women. This finding highlights a crucial factor for cardiovascular disease prevention in this demographic.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Women's Health

Background:

  • Coronary heart disease (CHD) is a leading cause of death in women globally, with increasing incidence.
  • Estrogen decline post-menopause elevates cardiovascular disease risk in women.
  • Risk factors for CHD in postmenopausal women require further clarification.

Purpose of the Study:

  • To systematically evaluate risk factors for coronary heart disease (CHD) specifically in postmenopausal women.
  • To identify key predictors of CHD incidence and mortality in this population.

Main Methods:

  • Comprehensive literature search across multiple databases (PubMed, Embase, Web of Science, etc.) up to February 2024.
  • Independent data extraction and quality assessment by two researchers.
  • Meta-analysis using STATA17.0 software to synthesize findings from included studies.

Main Results:

  • Nine studies encompassing 294,103 patients were included in the meta-analysis.
  • A history of six or more pregnancies was significantly associated with an increased risk of CHD (HR=1.538, 95% CI: 1.241%-1.906%, P < 0.05).

Conclusions:

  • Multiple pregnancies represent a significant risk factor for coronary heart disease (CHD) incidence and mortality in postmenopausal women.
  • Further high-quality research is warranted to validate these findings and inform clinical practice.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741